Titre : Membre-4 de la famille-12 des transporteurs de solutés

Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reproducibility of Results
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Membre-4 de la famille-12 des transporteurs de solutés : Questions médicales les plus fréquentes", "headline": "Membre-4 de la famille-12 des transporteurs de solutés : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Membre-4 de la famille-12 des transporteurs de solutés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-17", "dateModified": "2025-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Membre-4 de la famille-12 des transporteurs de solutés" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Symporteurs des ions sodium-potassium-chlorure", "url": "https://questionsmedicales.fr/mesh/D028021", "about": { "@type": "MedicalCondition", "name": "Symporteurs des ions sodium-potassium-chlorure", "code": { "@type": "MedicalCode", "code": "D028021", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.543.585.937.875" } } }, "about": { "@type": "MedicalCondition", "name": "Membre-4 de la famille-12 des transporteurs de solutés", "alternateName": "Solute Carrier Family 12, Member 4", "code": { "@type": "MedicalCode", "code": "D064507", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Simon Franz Müller", "url": "https://questionsmedicales.fr/author/Simon%20Franz%20M%C3%BCller", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany." } }, { "@type": "Person", "name": "Joachim Geyer", "url": "https://questionsmedicales.fr/author/Joachim%20Geyer", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, Schubertstr. 81, D-35392 Giessen, Germany." } }, { "@type": "Person", "name": "Nipaporn Deejai", "url": "https://questionsmedicales.fr/author/Nipaporn%20Deejai", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Choochai Nettuwakul", "url": "https://questionsmedicales.fr/author/Choochai%20Nettuwakul", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } }, { "@type": "Person", "name": "Nunghathai Sawasdee", "url": "https://questionsmedicales.fr/author/Nunghathai%20Sawasdee", "affiliation": { "@type": "Organization", "name": "Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Single Cerebral Organoid Mass Spectrometry of Cell-Specific Protein and Glycosphingolipid Traits.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36724094", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.analchem.2c00981" } }, { "@type": "ScholarlyArticle", "name": "Can a Computational Model Predict the Effect of Lesion Location on Cam-type Hip Impingement?", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36724209", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/CORR.0000000000002565" } }, { "@type": "ScholarlyArticle", "name": "The role of consciously timed movements in shaping and improving auditory timing.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36722075", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1098/rspb.2022.2060" } }, { "@type": "ScholarlyArticle", "name": "Development of a Scale to Measure Healthy Behaviors in Spanish-Speaking University Students.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36767993", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20032627" } }, { "@type": "ScholarlyArticle", "name": "Simultaneous quantification of venetoclax and voriconazole in human plasma by UHPLC-MS/MS and its application in acute myeloid leukemia patients.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36739719", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpba.2023.115279" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines membranaires", "item": "https://questionsmedicales.fr/mesh/D008565" }, { "@type": "ListItem", "position": 5, "name": "Protéines de transport membranaire", "item": "https://questionsmedicales.fr/mesh/D026901" }, { "@type": "ListItem", "position": 6, "name": "Protéines transporteurs de solutés", "item": "https://questionsmedicales.fr/mesh/D000070590" }, { "@type": "ListItem", "position": 7, "name": "Symporteurs des ions sodium-potassium-chlorure", "item": "https://questionsmedicales.fr/mesh/D028021" }, { "@type": "ListItem", "position": 8, "name": "Membre-4 de la famille-12 des transporteurs de solutés", "item": "https://questionsmedicales.fr/mesh/D064507" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Membre-4 de la famille-12 des transporteurs de solutés - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Comment diagnostiquer une dysfonction de SLC12A4 ?\nQuels tests sont utilisés pour évaluer SLC12A4 ?\nY a-t-il des marqueurs spécifiques pour SLC12A4 ?\nLes imageries médicales aident-elles au diagnostic ?\nLe diagnostic nécessite-t-il une biopsie ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels sont les symptômes d'une anomalie de SLC12A4 ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes sont-ils toujours présents ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Comment prévenir les troubles liés à SLC12A4 ?\nY a-t-il des tests de dépistage recommandés ?\nLes conseils génétiques sont-ils utiles ?\nLes vaccinations influencent-elles SLC12A4 ?\nL'exercice physique aide-t-il à prévenir les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels traitements sont disponibles pour SLC12A4 ?\nLa thérapie génique est-elle une option ?\nLes changements alimentaires aident-ils ?\nDes traitements symptomatiques existent-ils ?\nLes traitements sont-ils personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quelles complications peuvent survenir avec SLC12A4 ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nDes soins palliatifs sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Membre-4 de la famille-12 des transporteurs de solutés", "description": "Quels sont les facteurs de risque pour SLC12A4 ?\nL'environnement influence-t-il SLC12A4 ?\nLe mode de vie joue-t-il un rôle ?\nLes infections augmentent-elles le risque ?\nL'âge est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D064507?mesh_terms=Reproducibility+of+Results&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction de SLC12A4 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des analyses biochimiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer SLC12A4 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de transport ionique et des analyses de sang peuvent être effectués." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour SLC12A4 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs spécifiques largement reconnus." } }, { "@type": "Question", "name": "Les imageries médicales aident-elles au diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les imageries peuvent aider à évaluer des anomalies, mais ne sont pas spécifiques." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il une biopsie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie n'est généralement pas nécessaire pour diagnostiquer SLC12A4." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une anomalie de SLC12A4 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des déséquilibres électrolytiques et des troubles neurologiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les signes de déshydratation et de fatigue excessive." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains patients peuvent être asymptomatiques malgré une anomalie." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sans traitement, les symptômes peuvent s'aggraver avec le temps." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés à SLC12A4 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et une hydratation adéquate peuvent aider à prévenir les troubles." } }, { "@type": "Question", "name": "Y a-t-il des tests de dépistage recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être recommandés pour les familles à risque." } }, { "@type": "Question", "name": "Les conseils génétiques sont-ils utiles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conseils génétiques peuvent aider à évaluer le risque familial." } }, { "@type": "Question", "name": "Les vaccinations influencent-elles SLC12A4 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations n'ont pas d'impact direct sur SLC12A4." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir les symptômes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un exercice régulier peut contribuer à une meilleure santé globale, mais pas spécifique." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour SLC12A4 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments électrolytiques et des médicaments spécifiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore une option standard." } }, { "@type": "Question", "name": "Les changements alimentaires aident-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un régime équilibré peut aider à gérer les déséquilibres électrolytiques." } }, { "@type": "Question", "name": "Des traitements symptomatiques existent-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des traitements symptomatiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent être adaptés en fonction des besoins individuels." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec SLC12A4 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des troubles rénaux et des déséquilibres électrolytiques graves." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies associées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies métaboliques peuvent être associées à des anomalies de SLC12A4." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "Des soins palliatifs sont-ils nécessaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Dans les cas graves, des soins palliatifs peuvent être envisagés pour le confort." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour SLC12A4 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux et certaines conditions génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement influence-t-il SLC12A4 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent influencer l'expression de SLC12A4." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain peut exacerber les problèmes liés à SLC12A4." } }, { "@type": "Question", "name": "Les infections augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent aggraver les symptômes liés à SLC12A4." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut influencer la gravité des symptômes et des complications." } } ] } ] }

Sources (10000 au total)

Can a Computational Model Predict the Effect of Lesion Location on Cam-type Hip Impingement?

The Warwick consensus defined femoroacetabular impingement syndrome as a motion-related clinical disorder of the hip with a triad of symptoms, clinical signs, and imaging findings representing symptom... The purpose of this study was to examine the efficacy of a low computational cost approach to combining cam-type hip shape and multiple hip motions for predicting impingement. Specifically, we sought ... A model of the shape and alignment of a cam-type impinging hip was created and used to describe two locations of a cam lesion on the femoral head-neck junction (superior and anterior) based on joint s... The two locations of cam lesion generated impingement in a different percentage of motion cases (anterior cam: 56% of motion cases; superior cam: 13% of motion cases) and different areas of impingemen... This work demonstrated the capability of a simple, rapid computational tool to assess impingement of a specific cam-type hip shape (under 5 minutes for more than 100 motion cases). To our knowledge, t... The results of this study imply that patients with femoroacetabular impingement syndrome with cam lesions on the superior femoral head-neck junction may experience impinging during motions that are no...

Simultaneous quantification of venetoclax and voriconazole in human plasma by UHPLC-MS/MS and its application in acute myeloid leukemia patients.

Venetoclax, an orally bioavailable BCL-2 inhibitor, has been regarded as a breakthrough for the treatment of leukemia but has a wide interindividual variability and drug-drug interaction in pharmacoki...

Risk stratification of hospital admissions for COVID-19 pneumonia by chest radiographic scoring in a Johannesburg tertiary hospital.

Chest radiographic scoring systems for COVID-19 pneumonia have been developed. However, little is published on the utilityof these scoring systems in low- and middle-income countries.... To perform risk stratification of COVID-19 pneumonia in Johannesburg, South Africa (SA), by comparing the Brixia score withclinical parameters, disease course and clinical outcomes. To assess inter-ra... Retrospective investigation was conducted of adult participants with established COVID-19 pneumonia admitted at a tertiaryinstitution from 1 May to 30 June 2020. Two radiologists, blinded to clinical ... The cohort consisted of 263 patients, 51% male, with a median age of 47 years (interquartile range (IQR) = 20; 95% confidenceinterval (CI) 46.5 - 49.9). Hypertension (38.4%), diabetes (25.1%), obesity... We have demonstrated the utility of the Brixia scoring system in a middle-income country setting and developed the first SArisk stratification models incorporating comorbidities and a serological mark...

Item distribution, scalability and internal consistency of the QUALIDEM quality of life assessment for patients with dementia in acute hospital settings.

Quality of life (QoL) of people with dementia (PwD) is an important indicator of quality of care. Studying the impact of acute hospital settings on PwD's QoL requires assessment instruments that consi... Data stem from a study that analyzed the impact of a special care concept on the QoL of patients with dementia in acute hospitals. Total sample size consisted of N = 526 patients. Study nurses were tr... For people with mild to severe dementia, seven out of nine subscales were scalable (0.31 ≤ H ≤ 0.75). Five of these seven subscales were also internally consistent (ρ ≥ 0.69), while two had insufficie... In comparison with a previous evaluation of the QUALIDEM in a long-term care setting, the application in a hospital setting leads to very similar, acceptable results for people with mild to severe dem...